New York City-based NYU Langone Health recorded an operating income of $107.1 million (2.6% operating margin) in the second quarter of 2026, up from an operating income of $55 million (1.5% margin) during the same period last year, according to its April 29 financial report.
NYU Langone Health reported total operating revenue of $4.1 billion for the three months ended Feb. 28, up from $3.7 billion during the same period last year. Net patient service revenue was $3.2 billion, up from $2.7 billion. Pharmacy revenue was $358.4 million, up from $289.8 million.
Total operating expenses were $4 billion in the second quarter of 2026, up from $3.7 billion during the same period last year. Salaries, wages and benefits totaled $2.5 billion, up from $2.3 billion. Supplies and other expenses totaled $1.3 billion, up from $1.2 billion.
Within the health system, NYU Langone Hospitals recorded an operating income of $193.4 million during the second quarter of 2026, while the NYU Grossman Schools of Medicine recorded an operating loss of $86.5 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
